GOLD: Eli Lilly & Company and The Christie FT: New Models Of Complex Adjuvant Care In Patients With Early Breast Cancer

New adjuvant treatments for early breast cancer have recently been licensed in the UK, which is undoubtedly good news for patients. However, they also bring increased demand on clinical resources in breast cancer services. This was identified as a service delivery problem by The Christie and other oncology centres around the UK.

The Christie and Lilly UK together developed a joint working agreement to design and implement an innovative, centralised service for patients with early breast cancer utilising digital tools and innovative workforce solutions that could provide a blueprint for other cancer centres.

SILVER

Boehringer Ingelheim & United Lincolnshire Hospitals Trust: Improving Patient Health Outcomes And Optimisation Of Care Through The Development Of A Cardio-Diabetes Service And In-Reach Programme

BRONZE

University Hospitals Birmingham FT & MSD: Lung Cancer Pathway Development Programme (Collaborative Working Agreement)

 

Topics

Winners of HSJ Partnership Awards 2024 revealed